Found 169 matching trials
Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas EARLY_PHASE1 This is a multicenter, safety and pharmacokinetic trial to determine the MT...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial
A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma PHASE1 This is an open-label, multicenter, Phase Ib, dose-escalation and cohort-ex...
Show More Learn More & Join Trial
Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery PHASE1 This phase I trial studies the side effects and best dose of cabozantinib-s...
Show More Location
Emory University/Winship Cancer Institute
Learn More & Join Trial
Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study NA This study is looking at outcomes in people with advanced cancers who have ...
Show More Location
Peter MacCallum Cancer Centre
Learn More & Join Trial
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study PHASE3 This is an open-label, multicenter, extension study. Patients who are recei...
Show More Status
Active Not Recruiting
Location
University of Colorado Cancer Center
Learn More & Join Trial
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma PHASE2 Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
A Pharmacokinetics Study to Investigate the Effect of Vemurafenib on Digoxin in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma PHASE1 This open-label, multi-center, three-period, one sequence study will invest...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma PHASE1 This is a dose-seeking and efficacy study of combined BRAF Inhibitor Vemura...
Show More Location
Hillman Cancer Center
Learn More & Join Trial
The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs PHASE2 This is a prospective non-randomized national clinical phase 2 trial that a...
Show More Location
Turku University Hospital Cancer Centre
Learn More & Join Trial
Prognostic and Treatment-Response Factors in Metastatic Melanoma: Multi-Center Analysis N/A This multicenter, retrospective observational study aims to identify clinic...
Show More Location
Ankara Etlik City Hospital
Learn More & Join Trial